Jerry Charles Vega, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 66675 Pierson Blvd, Desert Hot Springs, CA 92240 Phone: 760-676-5240 |
Raquel M. Medeiros, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 12560 Palm Dr, Desert Hot Springs, CA 92240 Phone: 760-251-3401 Fax: 760-251-9592 |
Mr. Matthew Gaire Keane, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 66675 Pierson Blvd, Desert Hot Springs, CA 92240 Phone: 760-676-5240 |
Scott Cotteen, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 66675 Pierson Blvd, Desert Hot Springs, CA 92240 Phone: 760-676-5240 |
Samah Shaikh, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 12560 Palm Dr, Desert Hot Springs, CA 92240 Phone: 760-251-3401 |
Kim L Deprati, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 7885 Annandale Ave, Desert Hot Springs, CA 92240 Phone: 760-329-2924 |
News Archive
MMRGlobal, Inc. and VisiInc PLC have entered into an agreement to launch MMRGlobal's patented consumer and professional health IT products and services, including MMRPro for healthcare professionals and the MyMedicalRecords Personal Health Record (PHR), on the Visi platform utilizing the Vistime product.
As access to medical marijuana becomes more widespread, officials are debating its use as a pain-coping treatment and are easing rules for the sick to use the drug, The Wall Street Journal reports. "The U.S. Department of Justice has said it will not generally prosecute ill people under doctors' care whose use of the drug complies with state rules. New Jersey will become the 14th state to allow therapeutic use of marijuana, and the number is likely to grow. Illinois and New York, among others, are considering new laws."
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
Accumulating evidence suggests that the nucleus accumbens, which is involved in mechanisms of reward and addiction, plays a role in the pathogenesis of depression and in the action of antidepressants.
› Verified 5 days ago